| |
| |
|
| Insider
Information: |
Logan Carolyn J |
| Relationship: |
President & CEO, Direc... |
| City: |
Raleigh |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
703,838 |
|
|
Indirect Shares
|
400,000 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,103,838 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Salix Pharmaceuticals Ltd |
SLXP |
President & CEO, Direc... |
2014-12-22 |
703,838 |
2014-12-22 |
400,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2009-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,100 |
664,481 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2010-02-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,040 |
3,770 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2010-02-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,040 |
698,441 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2010-02-19 |
4 |
OE |
$1.13 |
$39,550 |
D/D |
35,000 |
699,481 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2010-05-10 |
4 |
OE |
$1.13 |
$45,200 |
D/D |
40,000 |
738,441 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2010-07-01 |
4 |
D |
$39.03 |
$1,482,906 |
D/D |
(37,994) |
700,447 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2010-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
65,560 |
766,007 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2010-09-21 |
4 |
S |
$42.35 |
$592,857 |
D/D |
(14,000) |
752,007 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2011-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
90,807 |
442,814 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2011-07-01 |
4 |
D |
$39.83 |
$1,531,344 |
D/D |
(38,447) |
404,367 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2011-09-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
900 |
4,220 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2011-09-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
900 |
403,467 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2012-04-13 |
4 |
OE |
$4.07 |
$81,400 |
D/D |
20,000 |
413,733 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2012-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
85,054 |
498,787 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2012-06-14 |
4 |
OE |
$4.07 |
$148,693 |
D/D |
36,534 |
535,321 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2012-06-28 |
4 |
AS |
$52.07 |
$6,211,832 |
D/D |
(119,300) |
644,488 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2012-06-28 |
4 |
OE |
$4.07 |
$929,861 |
D/D |
228,467 |
763,788 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2012-07-02 |
4 |
D |
$54.44 |
$944,915 |
D/D |
(17,357) |
627,131 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2012-12-20 |
4 |
OE |
$7.60 |
$256,500 |
D/D |
33,750 |
660,881 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2012-12-20 |
4 |
AS |
$42.27 |
$1,056,673 |
D/D |
(25,000) |
635,881 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2013-01-02 |
4 |
D |
$40.47 |
$901,186 |
D/D |
(22,268) |
613,613 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2013-04-18 |
4 |
A |
$48.70 |
$4,587,491 |
D/D |
94,199 |
707,812 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2013-06-10 |
4 |
GA |
$0.00 |
$0 |
D/D |
247,761 |
955,573 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2013-06-10 |
4 |
GD |
$0.00 |
$0 |
I/I |
400,000 |
0 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2013-07-01 |
4 |
D |
$66.15 |
$1,330,475 |
D/D |
(20,113) |
935,460 |
0 |
- |
|
59 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
